Severe COVID-19 in patients with hematological cancers presenting with viremia
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a danger to the health of populations around the world. Cancer is one of the comorbidities identified as being at risk of developing severe COVID-19.1 Among cancer patients, those with hematological cancers are at particularly high risk of severe disease or death.2, 3, 4 The reasons for developing severe COVID-19 in patients with hematological cancers, however, remain poorly understood. Here, we investigate clinical factors associated with higher risk for severe COVID-19 in patients with hematological cancers.
Annals of Oncology , éditorial en libre accès, 2021